Associations of FGF23 and Apelin-13 with osteoporosis and diabetic peripheral neuropathy in postmenopausal women with type 2 diabetes mellitus - Scorecard - MDSpire
Advertisement
Associations of FGF23 and Apelin-13 with osteoporosis and diabetic peripheral neuropathy in postmenopausal women with type 2 diabetes mellitus
Clinical Scorecard: Links Between FGF23 and Apelin-13 Levels with Osteoporosis and Diabetic Peripheral Neuropathy in Postmenopausal Women Diagnosed with Type 2 Diabetes Mellitus
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Care Setting
Clinical research setting focusing on osteoporosis and diabetic peripheral neuropathy.
Key Highlights
AUC_explanation
Guideline-Based Recommendations
Diagnosis
Management
Consider pharmacological interventions alongside monitoring FGF23 and Apelin-13 levels.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Include specific medications or lifestyle changes recommended.
Clinical Best Practices
Incorporate evidence-based guidelines for managing diabetic peripheral neuropathy.
